Document Detail


Difficult-to-control asthma in adults.
MedLine Citation:
PMID:  17765041     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Difficult-to-control asthma in adults is under-diagnosed and under-treated in the United States, particularly in those 40 years of age or older. Increasing attention has been focused on the subset of adult patients with poorly controlled asthma because they consume up to 85% of all health care dollars spent on asthma, while representing 20% of all asthma patients. In this article, we define difficult-to-control asthma and discuss the problem of misdiagnosis. We present an algorithm for confirming the diagnosis in these patients and highlight the importance of patient self-assessment.
Authors:
Forest H Mealey; Nicholas J Kenyon; Mark V Avdalovic; Samuel Louie
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  120     ISSN:  1555-7162     ISO Abbreviation:  Am. J. Med.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-03     Completed Date:  2007-09-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  760-3     Citation Subset:  AIM; IM    
Affiliation:
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, Davis, Sacramento 95817, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Algorithms
Ambulatory Care
Anti-Asthmatic Agents / therapeutic use
Antibodies, Monoclonal / therapeutic use
Asthma / diagnosis*,  prevention & control*
Bronchodilator Agents / therapeutic use
Glucocorticoids / therapeutic use
Humans
Leukotriene Antagonists / therapeutic use
Receptors, Adrenergic, beta-2 / agonists
Spirometry
Chemical
Reg. No./Substance:
0/Anti-Asthmatic Agents; 0/Antibodies, Monoclonal; 0/Bronchodilator Agents; 0/Glucocorticoids; 0/Leukotriene Antagonists; 0/Receptors, Adrenergic, beta-2; 0/omalizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prerenal success in chronic kidney disease.
Next Document:  Evaluation of the adult with suspected immunodeficiency.